1312 — Kontafarma China Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Kontafarma China Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	195	184	143	87.7	90.6
Net Total Accounts Receivable
Net Total Receivables	439	402	379	365	374
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	783	781	690	588	557
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	988	1,110	801	574	487
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,542	2,559	2,120	1,727	1,587
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	632	703	505	384	442
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,328	1,367	1,019	670	609
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,214	1,192	1,101	1,057	979
Total Liabilities & Shareholders' Equity	2,542	2,559	2,120	1,727	1,587
Total Common Shares Outstanding